Brief: Sagimet Biosciences Announces Leadership Changes
20/07/2023 21:23
July 20 (Reuters) - Sagimet Biosciences Inc SGMT.O :
* SAGIMET BIOSCIENCES ANNOUNCES LEADERSHIP CHANGES
* SAGIMET BIOSCIENCES INC SAYS ANTHONY M. RIMAC, WHO
CURRENTLY
SERVES AS CHIEF OPERATING OFFICER, WILL ASSUME POSITION OF CFO
AS OF AUGUST 1, 2023
* SAGIMET BIOSCIENCES INC SAYS DENNIS HOM, OUR CURRENT CFO,
WILL
CONTINUE TO SERVE IN AN ADVISORY CAPACITY FOR SEVERAL MONTHS
Source text for Eikon: ID:nGNX313r8k
Further company coverage: SGMT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage